Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novan Inc (NOVN)

Novan Inc (NOVN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 158,029
  • Shares Outstanding, K 18,813
  • Annual Sales, $ 4,920 K
  • Annual Income, $ -29,290 K
  • 60-Month Beta -0.02
  • Price/Sales 31.13
  • Price/Cash Flow N/A
  • Price/Book 5.75
Trade NOVN with:

Options Overview Details

View History
  • Implied Volatility 98.98%
  • Historical Volatility 57.53%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 202.06% on 07/07/21
  • IV Low 98.98% on 09/28/21
  • Put/Call Vol Ratio 0.02
  • Today's Volume 50
  • Volume Avg (30-Day) 191
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 955
  • Open Int (30-Day) 1,232

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.42
  • Number of Estimates 3
  • High Estimate -0.37
  • Low Estimate -0.50
  • Prior Year -0.60
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.02 +0.50%
on 09/28/21
10.40 -22.49%
on 09/08/21
-1.53 (-15.95%)
since 08/27/21
3-Month
7.48 +7.75%
on 07/29/21
10.58 -23.82%
on 08/12/21
-2.42 (-23.09%)
since 06/28/21
52-Week
4.33 +86.32%
on 10/07/20
25.90 -68.88%
on 02/16/21
+2.96 (+58.04%)
since 09/28/20

Most Recent Stories

More News
Global Multiple Myeloma Treatment Global Industry Trends, Competition Strategies, Revenue Analysis and Major Key Players 2029

Research Nester released a report titled which delivers detailed overview of the global multiple myeloma treatment drugs market in terms of market segmentation by drug class, therapy, distribution channel,...

BMY : 59.84 (unch)
AMGN : 212.27 (-0.39%)
JNJ : 162.81 (-0.22%)
MRK : 73.32 (-0.05%)
PFE : 43.04 (-1.22%)
SAN : 3.63 (-3.20%)
NOVN : 8.06 (-4.05%)
PHM : 47.19 (-2.38%)
Topical Pain Relief Market- Worldwide Industry Trends, Share, Size, Future Demand, Development Challenges, Top Countries Data and Forecast to 2028

Research Nester has released a reporttitled which also includes some of the prominent market analyzing parameters such as industry growth drivers, restraints, supply and demand risk, market attractiveness,...

SAN : 3.63 (-3.20%)
NOVN : 8.06 (-4.05%)
PFE : 43.04 (-1.22%)
GSK.LN : 1,383.000 (-0.30%)
Growth Hormone Deficiency Market- Worldwide Industry Trends, Share, Size, Future Demand, Development Challenges, Top Countries Data and Forecast to 2028

Research Nester published a report titled  which delivers a detailed overview of the growth hormone deficiency market in terms of market segmentation by application, by route of administration, by distribution...

TEVA : 9.60 (+3.90%)
NOVN : 8.06 (-4.05%)
PFE : 43.04 (-1.22%)
LLY : 221.60 (-2.12%)
MRK : 73.32 (-0.05%)
Global Multiple Myeloma Treatment Drugs Market Global Industry Demand, Innovative, Research Report, Future Estimation And Forecast[2029]

Research Nester released a report titled which delivers detailed overview of the global multiple myeloma treatment drugs market in terms of market segmentation by drug class, therapy, distribution channel,...

BMY : 59.84 (unch)
AMGN : 212.27 (-0.39%)
JNJ : 162.81 (-0.22%)
MRK : 73.32 (-0.05%)
PFE : 43.04 (-1.22%)
SAN : 3.63 (-3.20%)
NOVN : 8.06 (-4.05%)
PHM : 47.19 (-2.38%)
Sterile injectable drugs market Global Demand Analysis, Opportunity Outlook 2029 overview of the global sterile injectable drugs market

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated...

SAN : 3.63 (-3.20%)
PFE : 43.04 (-1.22%)
GSK : 38.05 (-1.17%)
BHC : 28.31 (-1.39%)
ABBV : 107.34 (-0.35%)
AMGN : 212.27 (-0.39%)
NOVN : 8.06 (-4.05%)
PROG : 0.8868 (-1.71%)
JNJ : 162.81 (-0.22%)
Global Packaging Machinery Market Growth to be driven by the Rising Demand of Packaged Consumer Goods 2029

Research Nester released a report titled which delivers a detailed overview of the global myeloproliferative disorder treatment market in terms of market segmentation by type, treatment, end-user, and...

BMY : 59.84 (unch)
INCY : 68.68 (-0.84%)
NOVN : 8.06 (-4.05%)
PFE : 43.04 (-1.22%)
TEVA : 9.60 (+3.90%)
DiGeorge Syndrome Drug Market in terms of market segmentation by therapy type, route of administration, end-user, and by region 2029

Research Nester released a report titled "" which delivers detailed overview of the DiGeorge syndrome drug market in terms of market segmentation by therapy type, route of administration, end-user, and...

PFE : 43.04 (-1.22%)
CERC : 2.93 (-1.68%)
BHC : 28.31 (-1.39%)
NTRA : 107.26 (-6.83%)
ABBV : 107.34 (-0.35%)
AMGN : 212.27 (-0.39%)
NOVN : 8.06 (-4.05%)
PROG : 0.8868 (-1.71%)
Adrenergic Drug Market- Future Growth Outlook, Revenue, COVID-19 Impact Analysis, Industry SWOT Analysis, Regional Forecast to 2028

Research Nester published a report titled "" which delivers detailed overview of the adrenergic drug market in terms of market segmentation by drug class, by route of administration, by disease indication,...

GSK.LN : 1,383.000 (-0.30%)
MRK : 73.32 (-0.05%)
TEVA : 9.60 (+3.90%)
AZN.LN : 8,474.000 (-1.09%)
NOVN : 8.06 (-4.05%)
PFE : 43.04 (-1.22%)
MYL : 15.86 (+1.96%)
NEXS : 0.0103 (+71.67%)
Head and Neck Squamous Cell Carcinoma (HNSCC) Treatment and Drugs Market: Segmented by Type, Application, Region And Forecast to 2029

Research Nester published a report titled which delivers detailed overview of the head and neck squamous cell carcinoma (HNSCC) treatment and drugs in terms of market segmentation by drug class, distribution...

IMMP : 4.13 (+2.23%)
FBIO : 3.40 (-3.95%)
NOVN : 8.06 (-4.05%)
LLY : 221.60 (-2.12%)
BMY : 59.84 (unch)
AZN.LN : 8,474.000 (-1.09%)
MRK : 73.32 (-0.05%)
PFE : 43.04 (-1.22%)
Hypertension Drugs Market: Global Demand, Share, Business Revenue, Top Players, Industry Analysis, Future Growth by 2029

Research Nester released a report titled which delivers detailed overview of the global hypertension drugs market in terms of market segmentation by drug class, type, distribution channel and by region....

PFE : 43.04 (-1.22%)
NOVN : 8.06 (-4.05%)
SAN : 3.63 (-3.20%)
MRK : 73.32 (-0.05%)
ABT : 118.74 (-1.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Novan, Inc. is a pharmaceutical company. It engaged in the development and commercialization of therapies using its nitric oxide platform for dermatology. The Company's product candidates primarily include SB204, SB206, SB208 and SB414 which are in pre-clinical trial stage. It develops product through...

See More

Key Turning Points

3rd Resistance Point 8.55
2nd Resistance Point 8.43
1st Resistance Point 8.25
Last Price 8.06
1st Support Level 7.95
2nd Support Level 7.83
3rd Support Level 7.65

See More

52-Week High 25.90
Fibonacci 61.8% 17.66
Fibonacci 50% 15.11
Fibonacci 38.2% 12.57
Last Price 8.06
52-Week Low 4.33

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar